Twist Loss, Tyson Profit Mark Mixed Q2 Results
Read, Watch or Listen
South San Francisco and Springdale: Twist Bioscience Corp. on Monday reported a $44 million loss in its fiscal second quarter, recording a loss of 71 cents per share (62 cents adjusted) and $110.7 million in revenue, while Springdale-based Tyson Foods Inc. on Monday reported $260 million in fiscal second-quarter earnings with $13.65 billion revenue. The immediate market effect this week included contrasting beats and misses against Zacks estimates: Twist’s revenue exceeded expectations but the company issued guidance of $114–$115 million for the current quarter and full-year revenue of $442–$447 million, while Tyson’s adjusted EPS beat estimates even as revenue fell short. Reports were distributed via AP/Automated Insights using Zacks data; analysts are expected to update forecasts in coming days.
Prepared by Christopher Adams and reviewed by editorial team.
Timeline of Events
- Zacks and other analysts published Q2 estimates ahead of earnings releases.
- Fiscal second-quarter periods ended for the reporting companies and accounting closed.
- On Monday, Twist Bioscience released Q2 results, including loss, revenue and guidance.
- On Monday, Tyson Foods released Q2 results, including profit, adjusted EPS and revenue.
- Automated AP summaries circulated and analysts prepare to revise forecasts and investor guidance.
Why This Matters to You
Twist Bioscience's loss and Tyson Foods' profit affect the stock market. If you own shares in these companies, you'll want to watch for updated forecasts. Even if you don't, these results can impact the overall market mood. Check your portfolio and consider talking to your financial advisor.
The Bottom Line
Twist Bioscience is in the red, but their revenue beat expectations. Tyson Foods is in the black, but their revenue fell short. It's a mixed bag, proving once again that business is unpredictable. Worth forwarding if you know someone who's invested in these companies.
- Articles Published:
- 4
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 4
- Distribution:
- Left 0%, Center 100%, Right 0%
Short-term traders, competitors, contract service providers and some suppliers may benefit from market reactions to the earnings reports and subsequent reallocation of orders and contracts.
Twist Bioscience shareholders and certain suppliers could suffer from the announced loss and any resulting reductions in spending or revised expectations; stakeholders tied to missed revenue targets at Tyson could face short-term pressure.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Center
Twist Loss, Tyson Profit Mark Mixed Q2 Results
San Francisco Gate WTOP WHAS 11 Louisville 9NEWSFrom Right
No right-leaning sources found for this story.
Comments